Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 9 studies | 26% ± 11% | |
| endothelial cell | 8 studies | 23% ± 6% | |
| microglial cell | 7 studies | 24% ± 7% | |
| epithelial cell | 7 studies | 37% ± 14% | |
| astrocyte | 7 studies | 32% ± 12% | |
| macrophage | 7 studies | 27% ± 5% | |
| myeloid cell | 5 studies | 23% ± 8% | |
| dendritic cell | 5 studies | 25% ± 10% | |
| fibroblast | 5 studies | 19% ± 5% | |
| type I pneumocyte | 5 studies | 21% ± 3% | |
| oligodendrocyte precursor cell | 5 studies | 32% ± 12% | |
| basal cell | 5 studies | 32% ± 17% | |
| B cell | 4 studies | 18% ± 2% | |
| hematopoietic precursor cell | 4 studies | 24% ± 8% | |
| retinal pigment epithelial cell | 4 studies | 37% ± 15% | |
| cardiac muscle cell | 4 studies | 18% ± 2% | |
| ciliated cell | 4 studies | 26% ± 8% | |
| type II pneumocyte | 4 studies | 22% ± 5% | |
| GABAergic neuron | 4 studies | 41% ± 11% | |
| glutamatergic neuron | 4 studies | 45% ± 9% | |
| monocyte | 4 studies | 21% ± 2% | |
| classical monocyte | 3 studies | 22% ± 5% | |
| conventional dendritic cell | 3 studies | 27% ± 10% | |
| lymphocyte | 3 studies | 21% ± 2% | |
| abnormal cell | 3 studies | 22% ± 7% | |
| granulocyte monocyte progenitor cell | 3 studies | 20% ± 3% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 7% | |
| intestinal crypt stem cell | 3 studies | 19% ± 3% | |
| alveolar macrophage | 3 studies | 21% ± 6% | |
| transit amplifying cell | 3 studies | 33% ± 21% | |
| interneuron | 3 studies | 44% ± 18% | |
| neuron | 3 studies | 33% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 1248.72 | 459 / 459 | 100% | 26.66 | 1118 / 1118 |
| esophagus | 100% | 1268.03 | 1445 / 1445 | 100% | 26.50 | 183 / 183 |
| stomach | 100% | 1047.39 | 359 / 359 | 100% | 35.89 | 286 / 286 |
| uterus | 100% | 1310.22 | 170 / 170 | 100% | 34.07 | 459 / 459 |
| brain | 100% | 1163.10 | 2640 / 2642 | 100% | 43.25 | 705 / 705 |
| thymus | 100% | 1183.45 | 653 / 653 | 100% | 26.42 | 604 / 605 |
| bladder | 100% | 1729.67 | 21 / 21 | 100% | 31.58 | 503 / 504 |
| intestine | 100% | 1636.42 | 966 / 966 | 100% | 41.65 | 525 / 527 |
| prostate | 100% | 1242.25 | 245 / 245 | 100% | 19.41 | 500 / 502 |
| ovary | 100% | 1247.82 | 180 / 180 | 100% | 14.57 | 428 / 430 |
| lung | 99% | 1098.75 | 575 / 578 | 100% | 24.60 | 1155 / 1155 |
| skin | 100% | 2415.20 | 1808 / 1809 | 99% | 42.29 | 467 / 472 |
| adrenal gland | 100% | 1714.21 | 258 / 258 | 99% | 21.47 | 227 / 230 |
| pancreas | 99% | 651.25 | 325 / 328 | 99% | 24.17 | 177 / 178 |
| kidney | 100% | 1110.92 | 89 / 89 | 98% | 17.58 | 884 / 901 |
| liver | 98% | 577.06 | 222 / 226 | 97% | 12.61 | 394 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 31.98 | 29 / 29 |
| spleen | 100% | 1107.57 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 25.55 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 11.81 | 1 / 1 |
| adipose | 100% | 1192.29 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 1339.85 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1177.13 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 1272.38 | 841 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 98% | 27.93 | 78 / 80 |
| peripheral blood | 77% | 739.45 | 712 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006366 | Biological process | transcription by RNA polymerase II |
| GO_0006368 | Biological process | transcription elongation by RNA polymerase II |
| GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0005674 | Cellular component | transcription factor TFIIF complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GTF2F2 |
| Protein name | General transcription factor IIF subunit 2 (Transcription initiation factor IIF subunit beta) General transcription factor IIF subunit 2 (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30) |
| Synonyms | RAP30 |
| Description | FUNCTION: TFIIF is a general transcription initiation factor that binds to RNA polymerase II and helps to recruit it to the initiation complex in collaboration with TFIIB. . |
| Accessions | ENST00000340473.8 P13984 ENST00000706694.1 A0A9L9PX76 |